Amarin Corporation plc, each representing one Ordinary Share (AMRN): Price and Financial Metrics
Today's Latest Price: $6.95 USD
Jul 6 12:03pm Add AMRN to Watchlist Sign Up AMRN Stock Summary The price/operating cash flow metric for Amarin Corp Plc is higher than 96.25% of stocks in our set with a positive cash flow. With a year-over-year growth in debt of -43.62%, Amarin Corp Plc's debt growth rate surpasses just 6.24% of about US stocks. As for revenue growth, note that AMRN's revenue has grown 97.8% over the past 12 months; that beats the revenue growth of 94.14% of US companies in our set. Stocks with similar financial metrics, market capitalization, and price volatility to Amarin Corp Plc are OFIX, QRHC, VG, CRY, and WLDN. AMRN's SEC filings can be seen here. And to visit Amarin Corp Plc's official web site, go to www.amarincorp.com. AMRN Price/Volume Stats
2.68B Amarin Corporation plc, each representing one Ordinary Share (AMRN) Company Bio
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.
AMRN Latest News Stream
All News Types Commentary Corp. News Debt Offering Earnings Guidance Down Guidance Up Insider Buying New Coverage (Bearish) New Coverage (Bullish) Product News PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Resumes Coverage (Bullish) Stock Offering
Event/Time News Detail Loading, please wait... Latest AMRN News From Around the Web
Below are the latest news stories about Amarin Corp Plc that investors may wish to consider to help them evaluate AMRN as an investment opportunity.
Amarin Corporation plc's (NASDAQ:AMRN): Amarin Corporation plc, a pharmaceutical company, develops and commercializes...
In the latest trading session, Amarin (AMRN) closed at $7.03, marking a +1.59% move from the previous day.
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
In the latest trading session, Amarin (AMRN) closed at $6.92, marking a +0.58% move from the previous day.
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin. Shares of the clinical biotechnology company were shattered at the end of March after the Nevada Court ruled in favor of two generic companies in the patent litigation case related to the generic […]
Read More 'AMRN' Stories Here
AMRN Price Returns
92.86% Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 1.0906 seconds.